Topical tacrolimus 0.03% monotherapy for vernal keratoconjunctivitis - Case series

British Journal of Ophthalmology

Volumn 94, Issue 10, 2010, Pages 1405-1406

  Tam, P M K ^a   Young, Alvin L ^a   Cheng, L L ^a   Lam, P T H ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; TACROLIMUS;

BURNING SENSATION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; LETTER; MAST CELL; PHOTOPHOBIA; PRIORITY JOURNAL; PSEUDOPHAKIA; VERNAL CONJUNCTIVITIS; VISION; VISUAL IMPAIRMENT;

ADMINISTRATION, TOPICAL; CHILD; CONJUNCTIVITIS, ALLERGIC; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; TACROLIMUS; YOUNG ADULT;

EID: 77958527634     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2009.172387     Document Type: Letter

References (6)

1. Siddique M, Manzouri B, Flynn TH, et al. Allergy and contact lenses. Chem Immunol Allergy 2007;92:166-75.
2. Cetinkaya A, Akova YA, Dursun D, et al. Topical cyclosporine in the management of shield ulcers. Cornea 2004;23:194-200.
3. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporine A and FK506. Immunol Today 1992;13:136-42.
4. Kymionis GD, Goldman D, Ide T, et al. Tacrolimus ointment 0.03% in the eye for treatment of giant papillary conjunctivitis. Cornea 2008;27:228-9.
5. Tam PM, Young AL, Cheng LL, et al. Topical 0.03% tacrolimus ointment in the management of ocular surface inflammation in chronic graft-versus-host- disease. Bone Marrow Transplant 2009; advance online publication 5 Oct 2009.
6. Attas-Fox L, Barkana Y, Iskhakov V, et al. Topical tacrolimus 0.03% ointment for intractable allergic conjunctivitis: an open-label pilot study. Curr Eye Res 2008;33:545-9. (Pubitemid 351948486)